Two different therapeutic modalities in the treatment of the upper extremity deep vein thrombosis: Preliminary investigation with 20 case reports

2011 ◽  
Vol 9 (01) ◽  
pp. 46-50 ◽  
Author(s):  
Ioannis Petrakis ◽  
Asterios Katsamouris ◽  
Efthimios Kafassis ◽  
Mauro D'Anna ◽  
Vincenzo Sciacca
Keyword(s):  
Deep Vein Thrombosis ◽  
Upper Extremity ◽  
Case Reports ◽  
Preliminary Investigation ◽  
Therapeutic Modalities ◽  
Vein Thrombosis ◽  
Deep Vein

scholarly journals Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19

Viruses ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 878
Author(s):  
Yesha H. Parekh ◽  
Nicole J. Altomare ◽  
Erin P. McDonnell ◽  
Martin J. Blaser ◽  
Payal D. Parikh
Keyword(s):  
Deep Vein Thrombosis ◽  
Lower Extremity ◽  
Upper Extremity ◽  
Thromboembolic Events ◽  
Vein Thrombosis ◽  
Venous Thromboembolic Events ◽  
Venous Thromboembolic ◽  
Deep Vein

Infection with SARS-CoV-2 leading to COVID-19 induces hyperinflammatory and hypercoagulable states, resulting in arterial and venous thromboembolic events. Deep vein thrombosis (DVT) has been well reported in COVID-19 patients. While most DVTs occur in a lower extremity, involvement of the upper extremity is uncommon. In this report, we describe the first reported patient with an upper extremity DVT recurrence secondary to COVID-19 infection.

Prevalence and clinical outcomes of hospitalized patients with Upper-Extremity Deep Vein Thrombosis

2021 ◽  
Author(s):  
Rafael S. Cires-Drouet ◽  
Frederick Durham ◽  
Jashank Sharma ◽  
Praveen Cheeka ◽  
Zachary Strumpf ◽  
...  
Keyword(s):  
Deep Vein Thrombosis ◽  
Clinical Outcomes ◽  
Upper Extremity ◽  
Hospitalized Patients ◽  
Vein Thrombosis ◽  
Deep Vein

Upper-extremity deep vein thrombosis and paralysis: A case report

2003 ◽  
Vol 84 (3) ◽  
pp. 458-459 ◽  
Author(s):  
Mrugeshkumar K. Shah ◽  
Randie M. Black-Schaffer
Keyword(s):  
Deep Vein Thrombosis ◽  
Case Report ◽  
Upper Extremity ◽  
Vein Thrombosis ◽  
Deep Vein

scholarly journals Association between Cancer and Anatomical Site of Venous Thromboembolic Disease

Blood ◽  
2020 ◽  
Vol 136 (Supplement 1) ◽  
pp. 6-6
Author(s):  
David A Froehling ◽  
Damon E. Houghton ◽  
Waldemar E. Wysokinski ◽  
Robert D. McBane ◽  
Danielle Vlazny ◽  
...  
Keyword(s):  
Deep Vein Thrombosis ◽  
Upper Extremity ◽  
Renal Vein ◽  
The Body ◽  
Published Data ◽  
Anatomical Site ◽  
Pulmonary Emboli ◽  
Vein Thrombosis ◽  
Deep Vein ◽  
Active Cancer

Background:There is limited published data on the association between malignancy and the location of venous thromboembolism (VTE) in the body. Aims:Assess the location of VTE in the body in patients with active cancer and compare these results in patients without malignancy. Methods:Consecutive patients enrolled in the Mayo Clinic VTE Registry between March 1, 2013 and November 30, 2019 for acute VTE were followed prospectively. Anatomical site of thrombosis and malignancy status were recorded. Patient outcomes were assessed in person, by mailed questionnaire, or by a scripted phone interview. Active cancer was defined as treatment for malignancy within the last six months or not yet in remission. Results:During the study period there were 2,798 patients with acute VTE (1256 with and 1542 without active cancer). Pulmonary emboli were more common in patients with active cancer compared to patients without cancer (49.5% vs. 39.7%, p<0.001). Upper extremity deep vein thrombosis (11.4 % vs. 7.7%, p<0.001), renal vein thrombi (1.4% vs. 0.2%, p<0.001) and splanchnic vein thrombi (9.3% vs. 6.0%, p=0.001) were all more common in patients with active cancer compared to patients without cancer. Conclusion:Compared to those without malignancy, patients with active cancer were more likely to have pulmonary emboli, upper extremity deep vein thrombosis, renal vein thrombi, and splanchnic vein thrombi. Disclosures No relevant conflicts of interest to declare.

Sign in / Sign up

Export Citation Format

Share Document